Information for Melanotan II
Page information·measured at build time
Technical and provenance information about Melanotan II. All figures on this page are measured from the emitted page rather than declared.
Basic information
| Display title | Melanotan II |
|---|---|
| Default sort key | Melanotan II |
| Namespace | Article (main) |
| Page kind | Compound |
| Page length (source, bytes) | 4,649 |
| Rendered word count | 540 |
| Internal wiki links on the page | 16 |
| Defined citations | 5 |
| Top-level sections | 3 |
| Subsections | 0 |
| Tables | 0 |
| Figures | 0 |
| Infobox | Yes — compound |
| Maintenance banners | medical |
| Indexing by robots | Allowed |
Edit history
| Page creator | ITT_Imelda |
|---|---|
| Date of page creation | 19 November 2024 |
| Latest editor | KPV_Kester |
| Date of latest edit | 14 July 2026 |
| Total number of edits | 30 |
| Total number of distinct authors | 25 |
| Minor edits | 11 |
| Automated (bot) edits | 2 |
| Recent number of edits (last 90 days) | 3 |
| Talk page posts | 4 |
Principal authors
| Editor | Edits | Share | Declared focus |
|---|---|---|---|
| GHK_Gwendolen | 3 | 10.0% | research peptides |
| ITT_Imelda | 2 | 6.7% | clinical trials and evidence appraisal |
| IpamorelinIsold | 2 | 6.7% | research peptides |
| Peptide_Pete | 2 | 6.7% | research peptides |
| Hedgerow_Hal | 1 | 3.3% | copy-editing and the manual of style |
| ShortDescShai | 1 | 3.3% | copy-editing and the manual of style |
| PriorAuthPaz | 1 | 3.3% | access, cost and insurance |
| StubSorterBot | 1 | 3.3% | categorisation and navigation |
| TriumphThad | 1 | 3.3% | clinical trials and evidence appraisal |
| API_Aurora | 1 | 3.3% | compounding law and drug regulation |
| MolarMassMaeve | 1 | 3.3% | GLP-1 receptor agonists and related compounds |
| DisclosureDido | 1 | 3.3% | policy, notability and deletion |
Category membership
- Category:Melanocortin agonists — 1 member pages
- Category:Research peptides — 3 member pages
- Category:Articles describing unapproved compounds — 21 member pages
- Category:Articles describing unapproved compounds (maintenance)